SILO PHARMA, INC. Proceeds from Issuance of Private Placement
SILO PHARMA, INC. (SILO) reported Proceeds from Issuance of Private Placement of $1.10 million for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2014-03-31
- SILO PHARMA, INC. proceeds from issuance of private placement for the quarter ending 2013-12-31 was $0.00.
- SILO PHARMA, INC. proceeds from issuance of private placement for fiscal 2013 was $1.10M.
| Period end | Proceeds from Issuance of Private Placement 1 month | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|---|---|
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $1.10M 10-K · filed 2014-03-31 | ||
| 2013-10-31 | $300.00K 10-Q · filed 2013-11-14 | |||
| 2013-09-30 | $1.10M 10-Q · filed 2013-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |